Twist Bioscience Corp (TWST): Total Assets
$641.86M
As of 2025-09-30
$672.44M
As of 2026-06-30
-12.6%
3-year compound annual growth
+10.0%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $641.86M | +4.5% | 2025-11-17, Balance as of period end |
| 2024-09-30 | $614.32M | -20.9% | 2025-11-17, Balance as of period end |
| 2023-09-30 | $776.40M | -19.2% | 2024-11-18, Balance as of period end |
| 2022-09-30 | $961.38M | +36.9% | 2023-11-21, Balance as of period end |
| 2021-09-30 | $702.10M | +76.0% | 2023-06-05, Balance as of period end |
| 2020-09-30 | $398.88M | +113.3% | 2021-11-23, Balance as of period end |
| 2019-09-30 | $186.99M | +61.5% | 2020-11-27, Balance as of period end |
| 2018-09-30 | $115.79M | n/a | 2019-12-13, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | 2025-09-30 | $641.86M | +4.5% |
| Krystal Biotech, Inc. (KRYS) | 2025-12-31 | $1.33B | +26.3% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | $1.07B | +5.7% |
| Tarsus Pharmaceuticals, Inc. (TARS) | 2025-12-31 | $562.16M | +49.1% |
| ADMA Biologics, Inc. (ADMA) | 2025-12-31 | $624.24M | +27.7% |
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | $512.74M | -4.9% |
| Vericel Corp (VCEL) | 2025-12-31 | $487.97M | +12.8% |
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | $913.17M | +0.3% |
| Vaxart, Inc. (VXRT) | 2025-12-31 | $186.08M | +11.8% |
Compare TWST, KRYS, IMCR, TARS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗